Last visit was: 18 May 2026, 03:36 It is currently 18 May 2026, 03:36
Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
User avatar
Bunuel
User avatar
Math Expert
Joined: 02 Sep 2009
Last visit: 18 May 2026
Posts: 110,574
Own Kudos:
815,486
 [9]
Given Kudos: 106,290
Products:
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 110,574
Kudos: 815,486
 [9]
Kudos
Add Kudos
9
Bookmarks
Bookmark this Post
User avatar
PyjamaScientist
User avatar
Admitted - Which School Forum Moderator
Joined: 25 Oct 2020
Last visit: 02 May 2026
Posts: 1,126
Own Kudos:
1,366
 [3]
Given Kudos: 633
GMAT 1: 740 Q49 V42 (Online)
Products:
GMAT 1: 740 Q49 V42 (Online)
Posts: 1,126
Kudos: 1,366
 [3]
2
Kudos
Add Kudos
1
Bookmarks
Bookmark this Post
User avatar
Tanvay
Joined: 07 Oct 2020
Last visit: 26 Jul 2022
Posts: 53
Own Kudos:
16
 [1]
Given Kudos: 16
Posts: 53
Kudos: 16
 [1]
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
User avatar
Tea12
Joined: 09 Aug 2018
Last visit: 21 Jul 2025
Posts: 19
Own Kudos:
Given Kudos: 26
Posts: 19
Kudos: 6
Kudos
Add Kudos
Bookmarks
Bookmark this Post
What should be our thought process to solve such type of strengthener questions, as they are quite tricky to solve in short span?
User avatar
vasu1104
Joined: 10 Feb 2023
Last visit: 18 May 2026
Posts: 462
Own Kudos:
Given Kudos: 670
Location: Canada
Products:
Posts: 462
Kudos: 266
Kudos
Add Kudos
Bookmarks
Bookmark this Post
when drug is being marketed to buyers, pharmaceutical companies mark down the price of new drug sold to pharmacies during trial phase.
during these trials, pharmacies often buy huge amount of the drug.
conclusion- pharmaceutical companies could profit more by not giving trials.

A. Generally, the quantity of markdown given by pharmaceutical companies to pharmacies is prudently calculated to be the least needed to attract buyers to the drug.
if quantity of markdown is less then not giving trials and making profits out of it doesnt make sense. because with the current one they are selling less at lower price so the assumption on which the conclusion was based doesnt get attacked, so reject.

B. For many drugs, the trial phase during which prices are lowered is about a month, which is not long enough for buyers to get used to the low price.
this talks about length of trial and that buyers not getting used to low price. both are not relevant here. reject.

C. The rationale of such trials is to keep the new drugs at the top of buyers’ minds and appeal to buyers now using competing drugs.
not concerned about whats actuall rationale from pharmaceutical companies side. reject.

D. Pharmacies often amass in their storage rooms drugs bought at markdown during trials and then sell these drugs later at regular prices.
perfect. this is the hidden link. if during the trial phase if companies can buy in large quantites and then sell later at lower price then definitely the pharma companies are loosing out on making profit from it. so the above mentioned plan definitely avoid this effect if plan implemented properly. keep.

E. If some pharmaceutical companies offer trials but other competing pharmaceutical companies do not, the companies that offer trials will lure buyers away from the other companies.
no effect at all. reject.
Bunuel
Occasionally, pharmaceutical companies mark down the price of a new drug sold to pharmacies during a trial phase, when the drug is being marketed to buyers. Such trials often cause pharmacies to buy a huge amount of the drug. Nonetheless, the pharmaceutical companies could often profit more by not giving trials.

Which of the following, if true, most strongly supports the claim above about the pharmaceutical companies’ profits?

A. Generally, the quantity of markdown given by pharmaceutical companies to pharmacies is prudently calculated to be the least needed to attract buyers to the drug.

B. For many drugs, the trial phase during which prices are lowered is about a month, which is not long enough for buyers to get used to the low price.

C. The rationale of such trials is to keep the new drugs at the top of buyers’ minds and appeal to buyers now using competing drugs.

D. Pharmacies often amass in their storage rooms drugs bought at markdown during trials and then sell these drugs later at regular prices.

E. If some pharmaceutical companies offer trials but other competing pharmaceutical companies do not, the companies that offer trials will lure buyers away from the other companies.
User avatar
vasu1104
Joined: 10 Feb 2023
Last visit: 18 May 2026
Posts: 462
Own Kudos:
Given Kudos: 670
Location: Canada
Products:
Posts: 462
Kudos: 266
Kudos
Add Kudos
Bookmarks
Bookmark this Post
when drug is being marketed to buyers, pharmaceutical companies mark down the price of new drug sold to pharmacies during trial phase.
during these trials, pharmacies often buy huge amount of the drug.
conclusion- pharmaceutical companies could profit more by not giving trials.

A. Generally, the quantity of markdown given by pharmaceutical companies to pharmacies is prudently calculated to be the least needed to attract buyers to the drug.
if quantity of markdown is less then not giving trials and making profits out of it doesnt make sense. because with the current one they are selling less at lower price so the assumption on which the conclusion was based doesnt get attacked, so reject.

B. For many drugs, the trial phase during which prices are lowered is about a month, which is not long enough for buyers to get used to the low price.
this talks about length of trial and that buyers not getting used to low price. both are not relevant here. reject.

C. The rationale of such trials is to keep the new drugs at the top of buyers’ minds and appeal to buyers now using competing drugs.
not concerned about whats actuall rationale from pharmaceutical companies side. reject.

D. Pharmacies often amass in their storage rooms drugs bought at markdown during trials and then sell these drugs later at regular prices.
perfect. this is the hidden link. if during the trial phase if companies can buy in large quantites and then sell later at lower price then definitely the pharma companies are loosing out on making profit from it. so the above mentioned plan definitely avoid this effect if plan implemented properly. keep.

E. If some pharmaceutical companies offer trials but other competing pharmaceutical companies do not, the companies that offer trials will lure buyers away from the other companies.
no effect at all. reject.
Bunuel
Occasionally, pharmaceutical companies mark down the price of a new drug sold to pharmacies during a trial phase, when the drug is being marketed to buyers. Such trials often cause pharmacies to buy a huge amount of the drug. Nonetheless, the pharmaceutical companies could often profit more by not giving trials.

Which of the following, if true, most strongly supports the claim above about the pharmaceutical companies’ profits?

A. Generally, the quantity of markdown given by pharmaceutical companies to pharmacies is prudently calculated to be the least needed to attract buyers to the drug.

B. For many drugs, the trial phase during which prices are lowered is about a month, which is not long enough for buyers to get used to the low price.

C. The rationale of such trials is to keep the new drugs at the top of buyers’ minds and appeal to buyers now using competing drugs.

D. Pharmacies often amass in their storage rooms drugs bought at markdown during trials and then sell these drugs later at regular prices.

E. If some pharmaceutical companies offer trials but other competing pharmaceutical companies do not, the companies that offer trials will lure buyers away from the other companies.
Moderators:
GMAT Club Verbal Expert
7393 posts
575 posts
368 posts